Tim Moore
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
4 flagsRep. Tim Moore sold $100K-$250K in Centene Corporation (CNC) on August 18, 2025 — 30 days before HJRES123, which aimed to disapprove a rule related to the Affordable Care Act's marketplace.
Rep. Tim Moore sold $50K-$100K in UnitedHealth Group (UNH) on August 15, 2025 — 83 days before S976, the Insurance Fraud Accountability Act, which would increase penalties for insurance fraud.
Rep. Tim Moore bought $15K-$50K in UnitedHealth Group (UNH) on August 8, 2025 — 85 days before a $782 million Department of Veterans Affairs contract was awarded to Optum Public Sector Solutions, Inc., a subsidiary of UnitedHealth Group.
Rep. Tim Moore sold $50K-$100K in UnitedHealth Group (UNH) on August 15, 2025 — 97 days before HR6166, the Lowering Drug Costs for American Families Act, which aims to reduce pharmaceutical company revenues.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | ETF | Yieldmax Smci Optn Inc Strg ETF - SMCY [OT](ETF) | $100K-$250K | — | — | — | Aug 7, 2025 |
| BUY | ETF | Direxion Daily Small Cap Bear 3X ETF - TZA [OT](ETF) | $50K-$100K | — | — | — | Aug 25, 2025 |
| BUY | $MSTY | Yieldmax MSTR Opt Incm Strtgy ETF (MSTY) [OT](ETF) | $50K-$100K | — | — | — | Aug 11, 2025 |
| BUY | $CNC | Centene Corporation Common Stock (CNC) [ST] | $15K-$50K | — | $41.09 | — | Aug 7, 2025 |
| BUY | ETF | Direxion Daily Small Cap Bear 3X ETF - TZA [OT](ETF) | $15K-$50K | — | — | — | Aug 14, 2025 |
| BUY | ETF | Direxion Daily Small Cap Bear 3X ETF - TZA [OT](ETF) | $15K-$50K | — | — | — | Aug 28, 2025 |
| BUY | $HY | Hyster-Yale, Inc. Class A common stock (HY) [ST] | $15K-$50K | — | — | — | Aug 12, 2025 |
| BUY | $HY | Hyster-Yale, Inc. Class A common stock (HY) [ST] | $15K-$50K | — | — | — | Aug 7, 2025 |
| BUY | $INTC | Intel Corporation - Common Stock (INTC) [ST] | $15K-$50K | — | — | — | Aug 8, 2025 |
| BUY | $INTC | Intel Corporation - Common Stock (INTC) [ST] | $15K-$50K | — | — | — | Aug 1, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Lowering Drug Costs for American Families Act
The Lowering Drug Costs for American Families Act directly reduces pharmaceutical company revenues by expanding federal drug price negotiation and extending Medicare inflation rebates to commercial markets. This legislation mandates significant revenue contraction for drug manufacturers and increases cost management pressure on health insurers due to new out-of-pocket limits. Pharmaceutical stocks will decline, while health insurer margins will tighten.
ANCHOR Act of 2025
The ANCHOR Act of 2025 expands Medicaid eligibility to uninsured individuals with serious mental illness or substance use disorder, creating a new revenue stream for healthcare providers and managed care organizations. This directly increases the total addressable market for behavioral health services and related diagnostics. Companies providing these services will see increased demand and reimbursement.
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $782M Department of Veterans Affairs Contract
This $782 million contract for EXPRESS REPORT services awarded to Optum Public Sector Solutions, Inc. is a significant win for parent company UnitedHealth Group ($UNH), bolstering its government healthcare technology segment and aligning with legislative efforts to improve healthcare services.
Medical Nutrition Therapy Act of 2025
The Medical Nutrition Therapy Act of 2025 (HR6199) is in the early stages of the legislative process, having been referred to two House committees. This bill aims to expand Medicare coverage for medical nutrition therapy to a wider range of chronic conditions and allow more healthcare professionals to make referrals, which would increase the total addressable market for nutrition-related services. While the bill does not appropriate funds, its passage would create new revenue streams for healthcare providers and retailers with nutrition programs.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability".
This joint resolution directly nullifies the CMS rule on Marketplace Integrity and Affordability, dismantling regulations that stabilize the Affordable Care Act (ACA) marketplace. Its passage increases uncertainty and volatility for health insurers operating within the ACA exchanges, leading to reduced profitability and potential market exits. Centene ($CNC) and Molina Healthcare ($MOH) are particularly exposed.
Increasing Access to Lung Cancer Screening Act
The Increasing Access to Lung Cancer Screening Act (HR6178) mandates no-cost lung cancer screenings and expanded tobacco cessation services under Medicaid, Medicare, and private insurance. This bill, if enacted, creates a guaranteed revenue stream for diagnostic and pharmaceutical companies, expanding their addressable market and increasing utilization.
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $895M Department of Veterans Affairs Contract
This $895 million Department of Veterans Affairs contract to Optum Public Sector Solutions, Inc., a subsidiary of UnitedHealth Group ($UNH), is bullish for the company. It represents a significant revenue stream in the healthcare technology sector, reinforced by legislative support for healthcare services.
Insurance Fraud Accountability Act
The Insurance Fraud Accountability Act (S.976) directly increases civil penalties for agents and brokers providing incorrect or fraudulent information for Qualified Health Plans, leading to higher compliance costs and potential fines for health insurance carriers. This legislation targets fraudulent enrollments under the Affordable Care Act, specifically impacting the profitability of health insurers. Historically, increased regulatory scrutiny in the health insurance sector has resulted in short-term stock value declines.
Foreign Robocall Elimination Act
The Foreign Robocall Elimination Act establishes an interagency taskforce to combat unlawful robocalls, increasing demand for advanced analytics and fraud prevention solutions. This directly benefits cybersecurity and analytics providers while increasing compliance costs for telecommunication companies. The bill creates a new market for specialized anti-robocall technologies.
Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025
The Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 (HR5199) has been introduced in the House and referred to two committees. This bill aims to expand independent practice authority for PAs and NPs in rural facilities, which could reduce operational costs for healthcare providers and insurers starting January 1, 2027, if enacted. The bill does not specify any direct funding amounts.
Live Charts
Other Filings by Tim Moore
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.